Women who breastfed for two years or longer had higher blood levels of anti-Müllerian hormone and later onset of menopause, compared to women who breastfed for one month or less, according to an
NICHD-supported analysis. The findings also suggest that previously observed relationships between menopause timing and the number of times a woman gave birth may be largely attributable to breastfeeding.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Spotlight: Boosting women’s health by supporting menstruation research
NICHD has supported gynecologic and reproductive health research for decades. Learn more about its leading role in menstruation research.
Release: Pregnancy, breastfeeding may lower risk of early menopause, NIH-funded study suggests
Women who breastfed their infants exclusively for 7 to 12 months may have a significantly lower risk of early menopause than their peers who breastfed their infants for less than a month, according to an analysis funded by the National Institutes of Health.
Item of Interest: Focus on FMR1: NIH Invites Comments on its Research Plan on Fragile X and Associated Conditions
NIH invites scientists, advocacy and family groups, representatives from federal and local agencies, and others to provide comments and suggestions on its draft research plan on Fragile X syndrome and associated conditions.
Getting to Know the New NICHD Director
NICHD Director Dr. Diana Bianchi shares some thoughts about joining NICHD.
Study finds genetic clue to menopause-like condition in young women
Six young women with a disorder that mimics menopause have gene alterations that hamper the repair of damaged DNA, report researchers supported by the National Institutes of Health.
May Wrap-Up: Promoting Women’s Health
Throughout May, the NICHD highlighted important information about women’s health, particularly women’s health research. These efforts coincided in part with National Women’s Health Week, from May 11 to 17.
Dr. Lisa Halvorson New Chief of Gynecologic Health and Disease Branch
Lisa M. Halvorson, M.D., has been named the new Chief of the Gynecologic Health and Disease Branch (GHDB), effective June 15, 2014, announced Dr. Catherine Spong, M.D., Director of the Division of Extramural Research.
A molecular explanation for age-related fertility decline in women
Scientists supported by the National Institutes of Health have a new theory as to why a woman’s fertility declines after her mid-30s. They also suggest an approach that might help slow the process, enhancing and prolonging fertility.
Scientific Vision: The Next Decade
On December 5, 2012, the NICHD released the Scientific Vision: The Next Decade, the culmination of a collaborative process that began in 2011 to identify the most promising scientific opportunities for the Institute and the research community to pursue over the next decade. The Vision statement was made available during the NICHD’s 50th anniversary colloquium.
NICHD reorganizes extramural program
Alan Guttmacher, M.D., Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) announced a number of changes to streamline the institute’s organizational structure and accelerate the exchange of scientific ideas.
NICHD vision statement now available online
A document charting a research course for the many collaborators who share an interest in promoting the science concerning human development through the life span, child health, women's health, and rehabilitation research is now available online.
Research for a Lifetime: Commemorating the NICHD’s 50th Anniversary
As the Institute marks its golden anniversary, we look back on the NICHD's early years, its scientific accomplishments, and its future.
Study Confirms Breast Cancer Risk in Continuous Combined Hormone Therapy Risk Begins to Return to Normal After Women Stop Taking Hormones
Researchers confirmed that a daily, combined dose of estrogen and progestin increases breast cancer risk in post menopausal women, but added that this risk begins to return to normal about six months after women stop taking the hormones.
BACK TO TOP